Current treatment of atypical mycobacteriosis - Wikidata - wikimedia - TriplyDB

Current treatment of atypical mycobacteriosis

Current treatment of atypical mycobacteriosis

http://www.wikidata.org/entity/Q28265322

about

Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation.Mycobacterium chelonae cutaneous infection in a patient with mixed connective tissue disease.Successful treatment of refractory cutaneous infection caused by Mycobacterium marinum with a combined regimen containing amikacin.Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria.The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: A case series and literature review.Sternal wound infection caused by Mycobacterium chelonae.Atypical mycobacterial cutaneous infections in Egyptians: a clinicopathological study.Multiple Pyoderma Gangrenosum Ulcers Associated with Cocaine Abuse.Mycobacterium kansasii cutaneous infection in a patient with sarcoidosis treated with anti-TNF agents.In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection model.

P2860

Q34481015-6A4FFE86-54F0-4FE0-86A5-59CE65AD6FCD Q35070340-759BB033-4AF4-4A92-BE9C-93BD9F3CC84F Q36444360-F2BA149A-DDA3-4E7A-ABB7-394086EA8AC8 Q37499353-29F2D394-3C11-4D31-9B17-4B8034EEC3B4 Q37832767-369C5FFF-9430-46E8-918E-9647DD598906 Q38128607-5FB37772-D99E-45F6-873E-12995F6C34D7 Q38988266-5B136187-7693-4276-8777-3904B84E468A Q42359476-73FA6FB0-DD65-4F55-B770-6E44B439A9CB Q51143237-34DC8535-AE7C-4BDD-A606-011CA17AA830 Q53187249-1F106065-39F3-4EB4-976B-81FBAFBA4837

P2860

Current treatment of atypical mycobacteriosis

http://www.wikidata.org/entity/Q28265322

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Current treatment of atypical mycobacteriosis

@ast

Current treatment of atypical mycobacteriosis

@en

Current treatment of atypical mycobacteriosis

@nl

type

label

Current treatment of atypical mycobacteriosis

@ast

Current treatment of atypical mycobacteriosis

@en

Current treatment of atypical mycobacteriosis

@nl

prefLabel

Current treatment of atypical mycobacteriosis

@ast

Current treatment of atypical mycobacteriosis

@en

Current treatment of atypical mycobacteriosis

@nl

P1433

Q28265322-2D4C5F11-A420-434A-A9BA-D36C29730DAC

P1476

Q28265322-88CDED3A-DA49-40BF-BCA0-12AD3804C065

P2093

Q28265322-658DA9B4-2747-4BAE-A942-E048526803C0

Q28265322-A8CD69F6-DE31-449F-9F86-0D1D979B6494

P2860

Q28265322-0441A7E3-EF5C-403F-8BA1-28226BAC4C49

Q28265322-04C0A16C-07B9-457A-A203-7A999FCA6EE4

Q28265322-09297FE4-D62F-4143-81B1-5D33303C81F0

Q28265322-0947679F-7BD0-445B-BDC8-D4CB7A0FC7D6

Q28265322-0A834FC1-28F7-4C5E-A810-8CF9F50CF5A2

Q28265322-0AA7FC72-4D79-4FAA-A352-F619F8B86F37

Q28265322-0F755975-A548-4B34-838C-1C058C8E6F6E

Q28265322-0FD6725A-8789-464C-A516-9D956F0DAA88

Q28265322-1FD077FD-666F-4863-8E95-F0C5B9D6F4C7

Q28265322-266B45A2-411F-41C6-AC0F-950CB2FCA884

P304

Q28265322-E77749C0-0FC9-46E6-9069-6E1E0A88C0C3

P31

Q28265322-6FC19B2A-8052-41A0-B5AE-DCD11C8E5A7D

P356

Q28265322-AAFA021C-A8EE-41C5-B4A9-D33655330EF5

P407

Q28265322-07BAF3C6-D5D2-4CE9-9099-40BA0B36228E

P433

Q28265322-9F357151-9D9E-4318-82BD-462BFDBD304F

P478

Q28265322-41527770-67DF-414A-A667-E6B6D3D4CA38

P577

Q28265322-1DA58F09-BBEF-418C-8993-2E30DC1C4BFC

P698

Q28265322-E178FF94-FD0A-4C58-8CC7-07059080E9AF

P356

14656560903369363

P1433

Expert Opinion on Pharmacotherapy

P1476

Current treatment of atypical mycobacteriosis

@en

P2093

Alberto Ortiz-Pérez

http://www.w3.org/2001/XMLSchema#string

Jaime Esteban

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria

Mycobacterium celatum sp. nov

Mycobacterium celatum, an emerging pathogen and cause of false positive amplified Mycobacterium tuberculosis direct test

Mycobacterial diseases other than tuberculosis

Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov

In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials

Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium

First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.

Mycobacterium haemophilum osteomyelitis: case report and review of the literature.

P304

2787-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656560903369363

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19929702

http://www.w3.org/2001/XMLSchema#string